Bayer has appointed Jost Reinhard as president of radiology business within its Pharmaceuticals Division, effective August 1, 2026.
Reinhard has spent more than 25 years at Bayer in roles spanning research and development, commercial operations, and strategic leadership, the company noted. He most recently served as head of investor relations at Bayer and previously led the company’s Cell and Gene Therapy unit in Boston. Earlier in his career, Reinhard held commercial leadership positions in Australia, Poland, and France. He holds a PhD in molecular toxicology and medicinal chemistry from the German Cancer Research Center in Heidelberg.
Reinhard succeeds Nelson Ambrogio, who became president of Bayer U.S. Pharmaceuticals in May 2026.